New asthma pill shows promise in large trial
NCT ID NCT03215758
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a daily pill called QAW039 can help people with uncontrolled asthma breathe better. 675 adults and teens took either the drug or a placebo for 12 weeks, on top of their usual inhalers. The main goal was to see if lung function improved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
QAW039 (a drug taken once daily by mouth)
What this could lead to
If it works, this could offer a new add-on treatment option for people whose asthma is not well controlled with current inhalers.
What could go wrong
This is a completed Phase 3 trial, but results are not yet widely known. The drug may not improve lung function enough to be approved, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Flagstaff, Arizona, 86001, United States
-
Novartis Investigative Site
Phoenix, Arizona, 85006, United States
-
Novartis Investigative Site
Huntington Beach, California, 92647, United States
-
Novartis Investigative Site
Long Beach, California, 90808, United States
-
Novartis Investigative Site
Los Angeles, California, 90025, United States
-
Novartis Investigative Site
Mission Viejo, California, 92691, United States
-
Novartis Investigative Site
Mountain View, California, 94040, United States
-
Novartis Investigative Site
Orange, California, 92868, United States
-
Novartis Investigative Site
Roseville, California, 95661, United States
-
Novartis Investigative Site
Walnut Creek, California, 94598, United States
-
Novartis Investigative Site
Denver, Colorado, 80206, United States
-
Novartis Investigative Site
Tamarac, Florida, 33321, United States
-
Novartis Investigative Site
Winter Park, Florida, 32789, United States
-
Novartis Investigative Site
Albany, Georgia, 31707, United States
-
Novartis Investigative Site
Dacula, Georgia, 30019, United States
-
Novartis Investigative Site
Honolulu, Hawaii, 96814, United States
-
Novartis Investigative Site
Lihue, Hawaii, 96766, United States
-
Novartis Investigative Site
Overland Park, Kansas, 66210, United States
-
Novartis Investigative Site
Louisville, Kentucky, 40215, United States
-
Novartis Investigative Site
Columbia, Missouri, 65203, United States
-
Novartis Investigative Site
Rolla, Missouri, 65401, United States
-
Novartis Investigative Site
Missoula, Montana, 59808, United States
-
Novartis Investigative Site
Bellevue, Nebraska, 68123, United States
-
Novartis Investigative Site
La Vista, Nebraska, 68128, United States
-
Novartis Investigative Site
Skillman, New Jersey, 08558, United States
-
Novartis Investigative Site
Asheville, North Carolina, 28801, United States
-
Novartis Investigative Site
Gastonia, North Carolina, 28054, United States
-
Novartis Investigative Site
High Point, North Carolina, 27262, United States
-
Novartis Investigative Site
Cincinnati, Ohio, 45231, United States
-
Novartis Investigative Site
Edmond, Oklahoma, 73034, United States
-
Novartis Investigative Site
Eugene, Oregon, 97401-4043, United States
-
Novartis Investigative Site
Medford, Oregon, 97504, United States
-
Novartis Investigative Site
Portland, Oregon, 97213, United States
-
Novartis Investigative Site
Portland, Oregon, 97220, United States
-
Novartis Investigative Site
Rapid City, South Dakota, 57701, United States
-
Novartis Investigative Site
Boerne, Texas, 78006, United States
-
Novartis Investigative Site
Dallas, Texas, 75231, United States
-
Novartis Investigative Site
El Paso, Texas, 79903, United States
-
Novartis Investigative Site
Fort Worth, Texas, 76109, United States
-
Novartis Investigative Site
McKinney, Texas, 75069, United States
-
Novartis Investigative Site
Seattle, Washington, 98122-4379, United States
-
Novartis Investigative Site
Greenfield, Wisconsin, 53228, United States
-
Novartis Investigative Site
Berazategui, Buenos Aires, 1888, Argentina
-
Novartis Investigative Site
CABA, Buenos Aires, C1056ABJ, Argentina
-
Novartis Investigative Site
CABA, Buenos Aires, C1122AAK, Argentina
-
Novartis Investigative Site
CABA, Buenos Aires, C1425BEN, Argentina
-
Novartis Investigative Site
CABA, Buenos Aires, C1426ABP, Argentina
-
Novartis Investigative Site
Lanus, Buenos Aires, B8000XAV, Argentina
-
Novartis Investigative Site
Mar del Plata, Buenos Aires, 7600, Argentina
-
Novartis Investigative Site
Santa Rosa, La Pampa Province, 6300, Argentina
-
Novartis Investigative Site
Buenos Aires, Nueve De Julio, B6500BWQ, Argentina
-
Novartis Investigative Site
Santa Fe, Rosario, S2000DBS, Argentina
-
Novartis Investigative Site
Rosario, Santa Fe Province, S2000BRH, Argentina
-
Novartis Investigative Site
Rosario, Santa Fe Province, S2000JKR, Argentina
-
Novartis Investigative Site
San Miguel de Tucumán, Tucumán Province, 4000, Argentina
-
Novartis Investigative Site
San Miguel de Tucumán, Tucumán Province, T4000IFL, Argentina
-
Novartis Investigative Site
Buenos Aires, C1012AAR, Argentina
-
Novartis Investigative Site
Buenos Aires, C1125ABE, Argentina
-
Novartis Investigative Site
Córdoba, X5003DCE, Argentina
-
Novartis Investigative Site
Mendoza, 5500, Argentina
-
Novartis Investigative Site
Mendoza, M5500CBA, Argentina
-
Novartis Investigative Site
Salta, 4000, Argentina
-
Novartis Investigative Site
Peine, Lower Saxony, 31224, Germany
-
Novartis Investigative Site
Cottbus, Saxony, 03050, Germany
-
Novartis Investigative Site
Aschaffenburg, 63739, Germany
-
Novartis Investigative Site
Bamberg, 96049, Germany
-
Novartis Investigative Site
Berlin, 12157, Germany
-
Novartis Investigative Site
Berlin, 12203, Germany
-
Novartis Investigative Site
Fürstenwalde, 15517, Germany
-
Novartis Investigative Site
Gauting, 82131, Germany
-
Novartis Investigative Site
Leipzig, 04275, Germany
-
Novartis Investigative Site
Lübeck, 23552, Germany
-
Novartis Investigative Site
Prien A Chiemsee, 83209, Germany
-
Novartis Investigative Site
Rüdersdorf, 15562, Germany
-
Novartis Investigative Site
Schleswig, 24837, Germany
-
Novartis Investigative Site
Schwerin, 19055, Germany
-
Novartis Investigative Site
Witten, 58452, Germany
-
Novartis Investigative Site
Budaörs, HUN, 2040, Hungary
-
Novartis Investigative Site
Ajka, 8400, Hungary
-
Novartis Investigative Site
Budapest, 1125, Hungary
-
Novartis Investigative Site
Debrecen, 4032, Hungary
-
Novartis Investigative Site
Gödöllő, 2100, Hungary
-
Novartis Investigative Site
Szeged, 6722, Hungary
-
Novartis Investigative Site
Culiacán, Sinaloa, 80230, Mexico
-
Novartis Investigative Site
Río de Janeiro, 06700, Mexico
-
Novartis Investigative Site
Lipa City, Batangas, 4217, Philippines
-
Novartis Investigative Site
Quezon City, Manila, 1100, Philippines
-
Novartis Investigative Site
Iloilo City, 5000, Philippines
-
Novartis Investigative Site
Manila, 1000, Philippines
-
Novartis Investigative Site
Riyadh, SAU, 11525, Saudi Arabia
-
Novartis Investigative Site
Jeddah, 21423, Saudi Arabia
-
Novartis Investigative Site
Bardejov, Slovak Republic, 085 01, Slovakia
-
Novartis Investigative Site
Kežmarok, 060 01, Slovakia
-
Novartis Investigative Site
Michalovce, 071 01, Slovakia
-
Novartis Investigative Site
Poprad, 058 01, Slovakia
-
Novartis Investigative Site
Prešov, 080 01, Slovakia
-
Novartis Investigative Site
Spišská Nová Ves, 052 01, Slovakia
-
Novartis Investigative Site
Žilina, 01207, Slovakia
-
Novartis Investigative Site
Tygerberg, Cape Town, 7505, South Africa
-
Novartis Investigative Site
Cape Town, 7500, South Africa
-
Novartis Investigative Site
Chatsworth, 4092, South Africa
-
Novartis Investigative Site
Durban, 4001, South Africa
-
Novartis Investigative Site
Pretoria, 0183, South Africa
-
Novartis Investigative Site
Istanbul, TUR, 34098, Turkey (Türkiye)
-
Novartis Investigative Site
Adana, 01330, Turkey (Türkiye)
-
Novartis Investigative Site
Ankara, 06100, Turkey (Türkiye)
-
Novartis Investigative Site
Istanbul, 34020, Turkey (Türkiye)
-
Novartis Investigative Site
Mersin, 33343, Turkey (Türkiye)
-
Novartis Investigative Site
Talas / Kayseri, 38039, Turkey (Türkiye)
-
Novartis Investigative Site
Yenisehir/Izmir, 35110, Turkey (Türkiye)